From Dealroom · · 50s
TL;DR: China's Tushen Zhihe raises hundreds of millions of yuan for AI protein design
Chinese AI startup Tushen Zhihe secures hundreds of millions of yuan in funding for drug design innovation.
Tushen Zhihe, a Chinese AI protein-design startup, raised hundreds of millions of yuan across Pre-A and Pre-A+ rounds to advance drug development through AI. Chinese AI startup Tushen Zhihe secures hundreds of millions of yuan in funding for drug design innovation. Tushen Zhihe raised hundreds of millions of yuan across Pre-A and Pre-A+ rounds with Shanghai STVC Group leading the Pre-A round.
- Funding Round
- AI Drug Design Focus
- Next Steps
Read the story version — the same reporting as a swipeable deck of 3 cards.

